7 天前 - … to the emergence and selection of clinically relevant multidrug-resistant bacteria.
In … the occurrence of Escherichia coli producing extended-spectrum β-lactamase (ESβL) in …

9 天前 - … coli are more challenging to treat, conferring a higher risk of bacteraemia …
Extended-spectrum β-lactamase (ESBL) production provides resistance to many clinically important …

14 天前 - … detection of extended spectrum β-lactamase genes in Escherichia coli clinical
isolates from … characterization of extended-spectrum β-lactamase producing enteroaggregative …

17 天前 - … cause extended-spectrum β-lactamase (ESBL) production in … clinical and
demographic characteristics of the patients were compared in terms of the isolated agent producing …

17 天前 - Escherichia coli is a notorious ubiquitous organism among the foodborne pathogens
which can form biofilm leading to the development of antibiotic resistance. We aimed to …

24 天前 - … coli isolates were collected from different clinical specimens. Antimicrobial susceptibility
… genotypic prevalence of extended-spectrum β-lactamase-producing Escherichia coli: a …

37 天前 - … coli isolates from the milk samples of bovine clinical mastitis in Tabriz City, Iran.
Also, the presence of the extended-spectrum β-Lactamase (… in the isolates. METHODS: In this …

44 天前 - … This study focused on measuring the prevalence of antimicrobial resistance bacteria
mostly by extended-spectrum β-lactamase (ESBL) producers from several samples in a …

61 天前 - … The most clinically relevant are those carrying genes encoding … , the β-lactamase
KPC-53, was isolated and characterized from … Extended-spectrum cephalosporins, piperacillin-…

68 天前 - … these are important because clinical isolates can possess … extended-spectrum
β-lactamases (ESBL) [51]. In this study, 40 … with pathogenic AmpC β-lactamase producers, mainly …